Author

Joao Santos

Institution: University of Helsinki

Observed institution: University of Helsinki

OpenAlex ID: A5109591000

722 Immunoprofiling and correlative analysis from PROTA: a phase I trial combining an oncolytic adenovirus encoding TNFα and IL2 with pembrolizumab for platinum-resistant or refractory ovarian cancer

2024 · James HA Clubb, Joao Santos, et al. · Journal for ImmunoTherapy of Cancer

715 Emerging results from the use of an oncolytic adenovirus armed with TNFa and IL-2 (TILT-123) in different phase I solid tumor clinical trials

2022 · Victor Cervera-Carrascon, Inge Svane, et al. · Journal for ImmunoTherapy of Cancer

Works count: 2

Citation count:

H-index:

I10-index: